bbc_business

Trump says he will hike tariffs on EU cars to 25%

trump said friday he's raising tariffs on eu cars and trucks to 25%, starting next week. he posted on truth social that the eu "is not complying with our fully agreed to trade deal" but didn't explain how.

car manufacturing is a big part of europe's economy, making this a sensitive target. the eu-us trade deal, agreed last july, had stalled over steel and aluminium disputes. germany and france had rejected us plans to adjust tariffs on a wider range of goods. trump urged european carmakers to move production to the us instead, saying if they build plants there, there will be "no tariff."

the 25% hike is a separate action from trump's "liberation day" tariffs, which the supreme court later ruled illegal. those tariffs fell under a different legal process, so this new round isn't affected by that ruling.

source: bbc_business
sentiment: -0.40 · impact: 0.80

Oil prices climb after disputed report of Iran strike on U.S. warship in the Strait of Hormuz

oil started the week higher on a disputed claim of an iranian strike on a u.s. navy ship in the strait of hormuz. the report, which hasn't been confirmed by u.s. officials, added fresh volatility to crude markets. the strait of hormuz is a key chokepoint

The markets are in the early stages of pricing in stagflation. Here’s what happens next.

source: marketwatch_top sentiment: -0.70 · impact: 0.80

Warsh's take on Fed independence is met with confusion and some concern

kevin warsh, trump's pick to lead the fed, is drawing confusion from six former fed officials over his views on fed independence. the sticking point: he draws a line between monetary policy — which he says should be "strictly independent" — and "non-monetary matters" like international

'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds

the weight-loss and diabetes drug boom is creating a bubble risk for pharma, according to a deloitte report out monday. r&d returns for the top 20 pharma companies hit 7% for a third straight year, driven almost entirely by glp-1 drugs like wegovy and zepbound. strip those out

Read more

Oil prices climb after disputed report of Iran strike on U.S. warship in the Strait of Hormuz

The markets are in the early stages of pricing in stagflation. Here’s what happens next.

Warsh's take on Fed independence is met with confusion and some concern

'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds